Notice Information
Notice Title
Logic Model and Impact Evaluation Methodology
Notice Description
The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545
Lot Information
Lot 1
The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02c149
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/014806-2021
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
79 - Business services: law, marketing, consulting, recruitment, printing and security
-
- CPV Codes
79000000 - Business services: law, marketing, consulting, recruitment, printing and security
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- £35,000 Under £100K
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 29 Jun 20214 years ago
- Submission Deadline
- 9 Jul 2021Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MEDICINES DISCOVERY CATAPULT
- Contact Name
- Mr Kieran McGowan
- Contact Email
- kieran.mcgowan@md.catapult.org.uk
- Contact Phone
- +44 1625708394
Buyer Location
- Locality
- CHESHIRE
- Postcode
- SK10 4TG
- Post Town
- Stockport
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD6 Cheshire
- Small Region (ITL 3)
- TLD62 Cheshire East
- Delivery Location
- TLD62 Cheshire East
-
- Local Authority
- Cheshire East
- Electoral Ward
- Chelford
- Westminster Constituency
- Tatton
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02c149-2021-06-29T11:59:52+01:00",
"date": "2021-06-29T11:59:52+01:00",
"ocid": "ocds-h6vhtk-02c149",
"initiationType": "tender",
"tender": {
"id": "DN553327",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Logic Model and Impact Evaluation Methodology",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "79000000",
"description": "Business services: law, marketing, consulting, recruitment, printing and security"
},
"mainProcurementCategory": "services",
"description": "The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545",
"lots": [
{
"id": "1",
"description": "The Catapult Centres are a network of world-leading centres designed to transform the UK's capability for innovation in specific areas and help drive future economic growth. (https://catapult.org.uk/catapult-centres/). Our specific area is medicines discovery. Part-funded by Innovate UK, an agency of the UK government, we are an independent not-for-profit company. We bring together industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high-value products. MDC is a national facility connecting the UK community to accelerate innovative drug discovery. We provide unique scientific capabilities and act as a gateway to UK resources and expertise, supporting UK SMEs in developing new medicines discovery approaches. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK's heritage position as a global leader in medicines R&D. MDC is currently in year 4 of our first 5-year grant funding agreement, referred to (GFA 1). To support our GFA1 evaluation, we have a logic model outlining our theory of change, and a supporting evaluation methodology framework, which we are in the process of implementing. In parallel to the work we are delivering for GFA 1, Innovate UK has asked that we develop our logic model and evaluation methodology framework to support our next grant funding agreement, GFA 2. The estimated value is between PS20,000.00 and PS35,000.00. Link to ITT documents here: https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545",
"value": {
"amount": 35000,
"currency": "GBP"
},
"contractPeriod": {
"endDate": "2021-10-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKD62"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2021-07-09T12:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2021-07-09T12:05:00+01:00"
},
"bidOpening": {
"date": "2021-07-09T12:05:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-1022",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"streetAddress": "Block 35, Mereside, Alderley Park",
"locality": "Cheshire",
"region": "UKD62",
"postalCode": "SK10 4TG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Mr Kieran McGowan",
"telephone": "+44 1625708394",
"email": "Kieran.McGowan@md.catapult.org.uk",
"url": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=2fb9a540-c5d8-eb11-810c-005056b64545"
},
"roles": [
"buyer",
"reviewBody"
],
"details": {
"url": "https://md.catapult.org.uk/",
"buyerProfile": "https://md.catapult.org.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"description": "Research - Drug Discovery / Health"
},
{
"scheme": "COFOG",
"description": "Research - Drug Discovery / Health"
}
]
},
"additionalContactPoints": [
{
"email": "kieran.mcgowan@md.catapult.org.uk"
}
]
}
],
"buyer": {
"id": "GB-FTS-1022",
"name": "Medicines Discovery Catapult"
},
"language": "en"
}